+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergency Contraceptive Pills Market by Product Type, Prescription Type, Dosage Form, Age Group, Distribution Channel - Global Forecast 2026-2032- Product Image
Emergency Contraceptive Pills Market by Product Type, Prescription Type, Dosage Form, Age Group, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Emergency Contraceptive Pills Market by Product Type, Prescription Type, Dosage Form, Age Group, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896594
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Emergency Contraceptive Pills Market is projected to reach USD 1.22 Billion in 2026. It is expected to continue growing at a CAGR of 6.76%, reaching USD 1.82 Billion by 2032.

Emergency contraceptive pills (ECPs) are time-sensitive reproductive health products used after unprotected sex, contraceptive failure, or sexual assault. The category includes levonorgestrel, ulipristal acetate, and combined oral contraceptive regimens, with World Health Organization guidance indicating that emergency contraception can prevent more than 95% of pregnancies when used within five days.

Demand is supported by the persistent global burden of unintended pregnancy, estimated by WHO and Guttmacher-linked research at about 121 million annually during 2015-2019. Market performance is shaped by over-the-counter availability, pharmacist counseling, digital health access, public policy, affordability, and the ability of manufacturers and distributors to maintain reliable, stigma-sensitive access.

Transformative Shifts in the ECP Landscape

The emergency contraceptive pills market is moving from episodic pharmacy purchases toward integrated reproductive health access. Regulatory shifts that allow nonprescription levonorgestrel access in many countries have expanded reach, while ulipristal acetate remains more tightly controlled in several markets due to prescribing and counseling requirements.

Telehealth, e-pharmacy, and direct-to-consumer education are changing how consumers obtain ECPs, particularly in markets where stigma, limited clinic availability, or travel time delays care. At the same time, policy volatility, misinformation, and uneven insurance coverage make evidence-based labeling, pharmacist training, and transparent safety communication critical competitive differentiators.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to affect the ECP value chain through demand sensing, inventory optimization, pharmacovigilance, and digital triage. AI-enabled models can help pharmacies and distributors anticipate demand spikes related to public health events, supply disruptions, weather emergencies, or local access changes, reducing stockouts for time-sensitive products.

The strongest opportunities are operational rather than promotional. Responsible AI can support multilingual education, flag adverse event patterns, improve route-to-market planning, and strengthen adherence to clinical guidance, but deployment must comply with privacy laws such as HIPAA and GDPR, avoid reproductive health surveillance risks, and be audited for bias in underserved populations.

Key Regional Insights

Asia-Pacific is a high-volume opportunity because of population scale, expanding pharmacy networks, rising smartphone-enabled health access, and unmet need for modern contraception, with China and India playing central roles in domestic production and demand. North America benefits from mature retail pharmacy access, especially for levonorgestrel in the United States and Canada, while prescription requirements for some products and insurance variability continue to shape channel strategy. Latin America shows pharmacy-led demand across urban centers, but uneven reproductive health policy, affordability barriers, and disparities between private and public access influence product availability.

Europe combines strong pharmacovigilance, established pharmacy infrastructure, and country-specific reimbursement and access rules that affect consumer choice between levonorgestrel and ulipristal acetate. The Middle East remains diverse, with higher-income urban markets supporting regulated private pharmacy access while cultural sensitivity requires discreet counseling and careful communication. Africa continues to face the sharpest access gaps, as urban private pharmacies expand availability but rural areas experience stockouts, stigma, provider shortages, and the need for stronger public-sector family planning integration.

Key Group Insights

ASEAN markets are characterized by varied regulatory pathways, uneven pharmacist authority, cross-border differences in reproductive health policy, and rising digital pharmacy adoption, creating opportunities for localized education and compliant omnichannel distribution. The GCC has higher purchasing power and regulated healthcare systems, but social sensitivity around reproductive health requires discreet access models, medically accurate counseling, and privacy-protective dispensing practices. The European Union provides a comparatively structured regulatory and safety framework, with national differences in pharmacy access, reimbursement, and age-related dispensing practices shaping commercialization.

BRICS countries combine large populations, domestic pharmaceutical manufacturing capacity, and significant unmet contraceptive need, making affordability, supply continuity, and public health alignment essential. G7 markets influence clinical standards, labeling, pharmacovigilance expectations, and digital health governance, often setting benchmarks for product safety communication. NATO is not a healthcare bloc, but member-country priorities around supply resilience, cybersecurity, emergency logistics, and critical infrastructure protection can indirectly affect pharmaceutical distribution planning for time-sensitive reproductive health products.

Key Country Insights

The United States has broad nonprescription levonorgestrel access, but state-level reproductive health dynamics, pharmacy availability, payer coverage, and consumer privacy concerns influence demand and dispensing behavior. Canada emphasizes pharmacist accessibility and regulated professional guidance, while Mexico and Brazil rely heavily on retail pharmacy channels where affordability, urban-rural access differences, and consumer education remain central. The United Kingdom, Germany, France, Italy, and Spain show mature pharmacy access with differing reimbursement, counseling, and prescribing practices, while Russia remains shaped by local prescribing norms, consumer awareness, and distribution conditions.

China and India are pivotal because of population size, domestic production, retail pharmacy expansion, and evolving consumer education around reproductive health. Japan and South Korea maintain more medically supervised access models than many Western markets, affecting speed to purchase and reinforcing the importance of clinician or pharmacist engagement. Australia supports pharmacy-based access with professional guidance, making timely dispensing, counseling on correct use, and referral pathways for ongoing contraception central to safe access.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize rapid, reliable access because ECP effectiveness is time dependent. Manufacturers and distributors need resilient inventory systems, clear product labeling, multilingual consumer education, and pharmacist training that addresses timing, drug interactions, body weight considerations, repeated use, side effects, and referral pathways for ongoing contraception and sexual health services.

Commercial strategy should combine compliant e-commerce, telehealth partnerships, and public health collaboration while protecting consumer privacy and avoiding stigmatizing messaging. Organizations using AI should implement privacy-by-design governance, bias testing, transparent model oversight, and human review. Leaders that align affordability, scientific credibility, discreet access, and supply reliability will be better positioned to build trust in a politically sensitive healthcare category.

Research Methodology

This executive summary is based on triangulation of public health guidance, regulatory references, clinical evidence, and market access indicators. Core sources include WHO emergency contraception guidance, CDC contraceptive practice recommendations, FDA and EMA regulatory information, UNFPA reproductive health context, and peer-reviewed evidence on unintended pregnancy, contraceptive access, and emergency contraception effectiveness.

The methodology emphasizes verified data over speculative market sizing. Findings are assessed through regulatory review, channel analysis, regional policy comparison, product availability mapping, pharmacovigilance context, and expert interpretation of pharmacy, telehealth, e-commerce, and public-sector family planning trends relevant to emergency contraceptive pills.

Conclusion

Emergency contraceptive pills remain an essential component of reproductive healthcare because they offer a safe, time-sensitive option after contraceptive failure or unprotected sex. The market is expanding through pharmacy access, digital health channels, and improved consumer awareness, but it remains highly sensitive to policy, stigma, affordability, privacy, and supply reliability.

Future growth will favor organizations that combine clinical accuracy with responsible distribution. Evidence-based education, resilient supply chains, privacy-protective digital tools, AI-enabled operational efficiency, and partnerships with pharmacists and public health systems will define leadership in the global emergency contraceptive pills market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Emergency Contraceptive Pills Market, by Product Type
7.1. Levonorgestrel
7.2. Mifepristone
7.3. Ulipristal Acetate
8. Emergency Contraceptive Pills Market, by Prescription Type
8.1. Over The Counter
8.2. Prescription
9. Emergency Contraceptive Pills Market, by Dosage Form
9.1. Single Dose
9.2. Multi-Dose
10. Emergency Contraceptive Pills Market, by Age Group
10.1. 15 to 19 Years
10.2. 20 to 24 Years
10.3. 25 to 29 Years
10.4. 30 Years & Above
11. Emergency Contraceptive Pills Market, by Distribution Channel
11.1. Hospital Pharmacies
11.2. Retail Pharmacies
11.3. Online Pharmacies
11.4. Clinics & Family Planning Centers
11.5. Nonprofit & Public Health Programs
12. Asia-Pacific Emergency Contraceptive Pills Market
13. North America Emergency Contraceptive Pills Market
14. Latin America Emergency Contraceptive Pills Market
15. Europe Emergency Contraceptive Pills Market
16. Middle East Emergency Contraceptive Pills Market
17. Africa Emergency Contraceptive Pills Market
18. ASEAN Emergency Contraceptive Pills Market
19. GCC Emergency Contraceptive Pills Market
20. European Union Emergency Contraceptive Pills Market
21. BRICS Emergency Contraceptive Pills Market
22. G7 Emergency Contraceptive Pills Market
23. NATO Emergency Contraceptive Pills Market
24. United States Emergency Contraceptive Pills Market
25. Canada Emergency Contraceptive Pills Market
26. Mexico Emergency Contraceptive Pills Market
27. Brazil Emergency Contraceptive Pills Market
28. United Kingdom Emergency Contraceptive Pills Market
29. Germany Emergency Contraceptive Pills Market
30. France Emergency Contraceptive Pills Market
31. Russia Emergency Contraceptive Pills Market
32. Italy Emergency Contraceptive Pills Market
33. Spain Emergency Contraceptive Pills Market
34. China Emergency Contraceptive Pills Market
35. India Emergency Contraceptive Pills Market
36. Japan Emergency Contraceptive Pills Market
37. Australia Emergency Contraceptive Pills Market
38. South Korea Emergency Contraceptive Pills Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Afaxys Pharma LLC
40.2. Alkem Laboratories Limited
40.3. Amneal Pharmaceuticals, Inc.
40.4. Apotex Inc
40.5. Aurobindo Pharma Limited
40.6. Bayer AG
40.7. Church & Dwight Co., Inc.
40.8. Cipla Ltd
40.9. CooperSurgical, Inc.
40.10. Dr. Reddy's Laboratories Ltd
40.11. Famy Care Limited
40.12. Fuji Pharma Co., Ltd.
40.13. Gedeon Richter Plc.
40.14. Glenmark Pharmaceuticals Limited
40.15. HLL Lifecare Limited
40.16. Johnson & Johnson Services, Inc.
40.17. Lupin Ltd
40.18. Mankind Pharma Ltd.
40.19. Perrigo Company plc
40.20. Piramal Enterprises Limited
40.21. Sandoz International GmbH
40.22. Sun Pharmaceutical Industries Ltd.
40.23. Teva Pharmaceutical Industries Ltd
40.24. Torrent Pharmaceuticals Limited
40.25. Viatris Inc
40.26. Watson Pharmaceuticals, Inc.
40.27. Zydus Lifesciences Limited
List of Figures
FIGURE 1. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2032 (%)
FIGURE 19. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 23. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL LEVONORGESTREL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL LEVONORGESTREL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL LEVONORGESTREL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MIFEPRISTONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MIFEPRISTONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MIFEPRISTONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ULIPRISTAL ACETATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ULIPRISTAL ACETATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ULIPRISTAL ACETATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL OVER THE COUNTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL OVER THE COUNTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL OVER THE COUNTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PRESCRIPTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PRESCRIPTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PRESCRIPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SINGLE DOSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SINGLE DOSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SINGLE DOSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MULTI-DOSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MULTI-DOSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MULTI-DOSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL 15 TO 19 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL 15 TO 19 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL 15 TO 19 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL 20 TO 24 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL 20 TO 24 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL 20 TO 24 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL 25 TO 29 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL 25 TO 29 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL 25 TO 29 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL 30 YEARS & ABOVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL 30 YEARS & ABOVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL 30 YEARS & ABOVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CLINICS & FAMILY PLANNING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CLINICS & FAMILY PLANNING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CLINICS & FAMILY PLANNING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NONPROFIT & PUBLIC HEALTH PROGRAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NONPROFIT & PUBLIC HEALTH PROGRAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NONPROFIT & PUBLIC HEALTH PROGRAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 63. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 64. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 65. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 66. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 82. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 83. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 84. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 87. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 88. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 94. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 95. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 96. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 100. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 101. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 102. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 106. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 107. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 108. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 111. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 113. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 114. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 117. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 118. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 119. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 120. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 124. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 125. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 126. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 130. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 131. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 132. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 134. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 136. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 137. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 138. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 140. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 142. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 143. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 144. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 146. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 147. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 148. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 149. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 150. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 152. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 154. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 155. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 156. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 158. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 160. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 161. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 162. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 163. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 166. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 167. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 168. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 172. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 173. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 174. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 176. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 178. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 179. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 180. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 184. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 185. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 186. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 187. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 188. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 189. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 190. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 191. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 192. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 194. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 195. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 196. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 197. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 198. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 200. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 202. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 203. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 204. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 205. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 207. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 208. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 209. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 210. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 214. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 215. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 216. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2032 (USD MILLION)
TABLE 220. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 221. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 222. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Emergency Contraceptive Pills market report include:
  • Afaxys Pharma LLC
  • Alkem Laboratories Limited
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc
  • Aurobindo Pharma Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Cipla Ltd
  • CooperSurgical, Inc.
  • Dr. Reddy's Laboratories Ltd
  • Famy Care Limited
  • Fuji Pharma Co., Ltd.
  • Gedeon Richter Plc.
  • Glenmark Pharmaceuticals Limited
  • HLL Lifecare Limited
  • Johnson & Johnson Services, Inc.
  • Lupin Ltd
  • Mankind Pharma Ltd.
  • Perrigo Company plc
  • Piramal Enterprises Limited
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Torrent Pharmaceuticals Limited
  • Viatris Inc
  • Watson Pharmaceuticals, Inc.
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages198
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.22 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.82 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Female Emergency Contraceptive Pill Market - Global Forecast 2026-2032 - Product Image

Female Emergency Contraceptive Pill Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Emergency Contraceptive Pills - Global Strategic Business Report - Product Image

Emergency Contraceptive Pills - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Female Contraceptive Market by Product Type, Mechanism, End User Age, Distribution Channel - Global Forecast 2026-2032 - Product Image

Female Contraceptive Market by Product Type, Mechanism, End User Age, Distribution Channel - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Emergency Contraceptive Pills Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032 - Product Image

Emergency Contraceptive Pills Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032

  • Report
  • 180 Pages
  • Global
From
Emergency Contraceptive Pills Market Report by Type, Distribution Channel, and Region 2026-2034 - Product Image

Emergency Contraceptive Pills Market Report by Type, Distribution Channel, and Region 2026-2034

  • Report
  • 136 Pages
  • Global
From

About the Emergency Contraception Market

Emergency contraception (EC) is a form of contraception used to prevent pregnancy after unprotected sexual intercourse. It is available in the form of pills, intrauterine devices (IUDs), and copper coils. EC is an important part of women's health, as it provides an option for women who have had unprotected sex or experienced contraceptive failure. EC is a safe and effective way to prevent unintended pregnancy, and can be used up to five days after unprotected sex. EC is available over-the-counter in many countries, and is also available by prescription in some countries. EC is a cost-effective form of contraception, and is often covered by health insurance plans. EC is also available through online pharmacies, allowing women to access EC without having to visit a doctor or pharmacy. Some companies in the EC market include HRA Pharma, Bayer, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.